Twist Bioscience, which manufactures synthetic genes and other DNA-based products, raised $70 million by offering 5 million shares at $14, the low end of the range of $14 to $16. Twist Bioscience plans to list on the Nasdaq under the symbol TWST. J.P. Morgan and Cowen acted as lead managers on the deal.
